Crucell and Scripps find antibody for universal flu vax

Researchers at Crucell and the Scripps Research Institute have discovered a new antibody that could lead to a universal flu vaccine. According to animal test results, the antibody, CR6261, neutralized multiple flu strains, including H3N2, which killed 1 million people in Asia during the late 1960s. And researchers have found CR8020 is a complementary antibody, which fights the flu strains not affected by CR6261. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.